BRIEF-Oncomed doses first patient with anti-tigit antibody in phase 1 clinical trial By: Reuters: Company News May 04, 2017 at 09:11 AM EDT * Oncomed doses first patient with anti-tigit antibody in phase 1 clinical trial Read More >> Related Stocks: Oncomed Pharma